Lung Cancer
Conference Coverage
A farewell to arms? Drug approvals based on single-arm trials can be flawed
Objective responses, not time-dependent survival outcomes, should be endpoints for single-arm trials, with results only used for conditional...
Conference Coverage
Time to cancer diagnoses in U.S. averages 5 months
Diagnosis time varied significantly across tumor types, as well as within the same tumor type.
News
Opioids after lung cancer surgery may up all-cause mortality risk
“New long-term opioid use may be associated with poor long-term survival outcomes, especially in potent opioid users.”
Conference Coverage
In NSCLC, not all EGFR mutations are the same
Patients with the Ex20 insertion may buck trend by responding well to ICIs.
Conference Coverage
In early NSCLC, comorbidities linked to survival
Respiratory and cardiometabolic comorbidities were associated with significantly worse overall survival in lung cancer.
Conference Coverage
‘Smoking gun–level’ evidence found linking air pollution with lung cancer
The finding could lead to strategies for preventing lung cancer in nonsmokers exposed to high levels of foul air.
Conference Coverage
Gene mutations may drive lung cancer in never-smokers
Study hints at mechanistic differences between small cell lung cancer in smokers versus nonsmokers.
Article
Reporting Coronary Artery Calcium on Low-Dose Computed Tomography Impacts Statin Management in a Lung Cancer Screening Population
Background: Cigarette smoking is an independent risk factor for atherosclerotic cardiovascular disease (ASCVD)....
